Effect of two new sulfonic acid esters of aminoglycols on chronic myelogenous leukemia.
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000605:Amino Alcohols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007958:Leukocyte Count; D008297:Male; D008744:Methylamines / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D011437:Propylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D013163:Splenomegaly / Q000188:drug therapy; D013451:Sulfonic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000477:Alkylating Agents; D000605:Amino Alcohols; D008744:Methylamines; D011437:Propylamines; D013451:Sulfonic Acids